- Home
- DYN vs ARR Comparison
DYN vs ARR Comparison
Compare DYN & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- ARR
- Stock Information
- Founded
- DYN 1984
- ARR 2008
- Country
- DYN United States
- ARR United States
- Employees
- DYN N/A
- ARR N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- ARR Real Estate Investment Trusts
- Sector
- DYN Health Care
- ARR Real Estate
- Exchange
- DYN Nasdaq
- ARR Nasdaq
- Market Cap
- DYN 1.9B
- ARR 1.8B
- IPO Year
- DYN 2020
- ARR N/A
- Fundamental
- Price
- DYN $22.76
- ARR $16.03
- Analyst Decision
- DYN Strong Buy
- ARR Buy
- Analyst Count
- DYN 14
- ARR 4
- Target Price
- DYN $34.93
- ARR $15.50
- AVG Volume (30 Days)
- DYN 2.9M
- ARR 3.0M
- Earning Date
- DYN 10-28-2025
- ARR 10-22-2025
- Dividend Yield
- DYN N/A
- ARR 18.06%
- EPS Growth
- DYN N/A
- ARR N/A
- EPS
- DYN N/A
- ARR 0.65
- Revenue
- DYN N/A
- ARR $116,798,000.00
- Revenue This Year
- DYN N/A
- ARR $350.86
- Revenue Next Year
- DYN N/A
- ARR $63.37
- P/E Ratio
- DYN N/A
- ARR $24.52
- Revenue Growth
- DYN N/A
- ARR N/A
- 52 Week Low
- DYN $6.36
- ARR $13.18
- 52 Week High
- DYN $35.68
- ARR $19.66
- Technical
- Relative Strength Index (RSI)
- DYN 74.02
- ARR 55.83
- Support Level
- DYN $23.05
- ARR $15.82
- Resistance Level
- DYN $25.00
- ARR $16.55
- Average True Range (ATR)
- DYN 1.00
- ARR 0.31
- MACD
- DYN 0.72
- ARR 0.01
- Stochastic Oscillator
- DYN 78.19
- ARR 51.15
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.